logo
Select company
Select metric
$ 80.47MNet Cash Flow - Investing
VS
Market
93
Sector
92
Industry
89
History
56
$ 34.63Close
$ 12.38 - $ 35.37 52-Week Range
Ticker Information

Ticker

ANAB

Company Name

ANAPTYSBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ANAPTYSBIO INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ANAB - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ 80.47M
3/31/2025$ 41.63M
12/31/2024$ 95.4M
9/30/2024$ 173.97M
6/30/2024$ 145.99M
3/31/2024$ 127.97M
12/31/2023$ 144.75M
9/30/2023$ 117.07M
6/30/2023$ 54M
3/31/2023$ 3.46M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ANAPTYSBIO INC's latest trailing twelve months (TTM) CF - Investing stands at $ 94.91M.
  • Over the past 5 years, ANAPTYSBIO INC's average CF - Investing has been $ -4.14M.
  • The median CF - Investing for ANAPTYSBIO INC during this period was $ 94.69M
  • ANAPTYSBIO INC reached its highest CF - Investing over the past 5 years at $ 173.97M.
  • The lowest CF - Investing recorded by ANAPTYSBIO INC in the same timeframe $ -483.04M

ANAPTYSBIO INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
PHAT : PHATHOM PHARMACEUTICALS INC $ -164KNAGE : NIAGEN BIOSCIENCE INC $ -257KGYRE : GYRE THERAPEUTICS INC $ -5.47MCRMD : CORMEDIX INC $ -14.39MXNCR : XENCOR INC $ -52.06MTBPH : THERAVANCE BIOPHARMA INC $ -7.34MZYME : ZYMEWORKS INC $ 86.97MKURA : KURA ONCOLOGY INC $ -91.89MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -217KZVRA : ZEVRA THERAPEUTICS INC $ -14.35M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

ANAB - Net Cash Flow - Investing, Last 5 years

$ -483.04M

Minimum

Sep 30, 2022

$ 173.97M

Maximum

Sep 30, 2024

$ -4.14M

Average

$ 94.69M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M